The synergistic effect of nanocurcumin and donepezil on Alzheimer's via PI3K/AKT/GSK-3β pathway modulating

被引:13
作者
Beltagy, Doha M. [1 ,4 ]
Nawar, Nagat F. [2 ]
Mohamed, Tarek M. [2 ]
Tousson, Ehab [3 ]
El-Keey, Mai M. [2 ]
机构
[1] Damanhour Univ, Fac Sci, Biochem Dept, Damanhour, Egypt
[2] Tanta Univ, Fac Sci, Chem Dept, Biochem Div, Tanta, Egypt
[3] Tanta Univ, Fac Sci, Dept Zool, Tanta, Egypt
[4] Damanhour Univ, Fac Sci, Damanhour, Egypt
关键词
Alzheimer 's; Nanocurcumin; Oxidative stress; Donepezil; Tau protein; Cholinesterase; CURCUMIN-LOADED NANOPARTICLES; SYSTEM; CELLS; MODEL; NEUROGENESIS; ALUMINUM; MEMORY;
D O I
10.1016/j.prostaglandins.2023.106791
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) hallmarks include amyloid-beta eta (A beta) and tau proteins aggregates, neurite degeneration, microglial activation with cognitive impairment. Phosphatidylinositol-3-kinase/protein kinase B/Glycogen synthase kinase-3-beta (PI3K/AKT/GSK-3) pathway is essential for neuroprotection, cell survival and proliferation by blocking apoptosis. This study aimed to assess protective role of nanocurcumin (NCMN) as strong antioxidant and anti-inflammatory agent with elucidating its synergistic effects with Donepezil as acetylcholinesterase inhibitor on AD in rats via modulating PI3K/AKT/GSK-3 beta pathway. The experiment was performed on 70 male Wistar albino rats divided into seven groups (control, NCMN, Donepezil, AD-model, Donepezil cotreatment, NCMN only co-treatment, and NCMN+Donepezil combined treatment). Behavioral and biochemical investigations as cholinesterase activity, oxidative stress (malondialdehyde, reduced glutathione, nitric oxide, superoxidedismutase, and catalase), tumor necrosis factor-alpha, Tau, beta-site amyloid precursor protein cleaving enzyme-1 (BACE-1), Phosphatase and tensin homolog (Pten), mitogen-activated protein kinase-1 (MAPK-1), Glycogen synthase kinase-3-beta (GSK-3 beta) and toll-like receptor-4 were evaluated. Treatment with NCMN improved memory, locomotion, neuronal differentiation by activating PI3K/AKT/GSK-3 beta pathway. These results were confirmed by histological studies in hippocampus.
引用
收藏
页数:9
相关论文
共 77 条
[31]   Glycogen synthase kinase-3 signaling in Alzheimer's disease [J].
Lauretti, Elisabetta ;
Dincer, Ozlem ;
Pratico, Domenico .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2020, 1867 (05)
[32]   A1-42 increases the expression of neural KATP subunits Kir6.2/SUR1 via the NF-B, p38 MAPK and PKC signal pathways in rat primary cholinergic neurons [J].
Li, Y. ;
Ba, M. ;
Du, Y. ;
Xia, C. ;
Tan, S. ;
Ng, K. P. ;
Ma, G. .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2019, 38 (06) :665-674
[33]   Curcumol allosterically modulates GABA(A) receptors in a manner distinct from benzodiazepines [J].
Liu, Yan-Mei ;
Fan, Hui-Ran ;
Ding, Jing ;
Huang, Chen ;
Deng, Shining ;
Zhu, Tailin ;
Xu, Tian-Le ;
Ge, Wei-Hong ;
Li, Wei-Guang ;
Li, Fei .
SCIENTIFIC REPORTS, 2017, 7
[34]   Application of curcumin nanoformulations in Alzheimer's disease: prevention, diagnosis and treatment [J].
Lv, Hongqian ;
Wang, Yan ;
Yang, Xiaotong ;
Ling, Guixia ;
Zhang, Peng .
NUTRITIONAL NEUROSCIENCE, 2023, 26 (08) :727-742
[35]   Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes [J].
Ly, Philip T. T. ;
Wu, Yili ;
Zou, Haiyan ;
Wang, Ruitao ;
Zhou, Weihui ;
Kinoshita, Ayae ;
Zhang, Mingming ;
Yang, Yi ;
Cai, Fang ;
Woodgett, James ;
Song, Weihong .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (01) :224-235
[36]   WIN55,212-2 Attenuates Cognitive Impairments in AlCl3 [J].
Mahdi, Onesimus ;
Chiroma, Samaila Musa ;
Hidayat Baharuldin, Mohamad Taufik ;
Mohd Nor, Nurul Huda ;
Mat Taib, Che Norma ;
Jagadeesan, Saravanan ;
Devi, Shamala ;
Mohd Moklas, Mohamad Aris .
BIOMEDICINES, 2021, 9 (09)
[37]   Oxidative stress, aging, antioxidant supplementation and their impact on human health: An overview [J].
Martemucci, Giovanni ;
Portincasa, Piero ;
Di Ciaula, Agostino ;
Mariano, Michele ;
Centonze, Vincenzo ;
D'Alessandro, Angela Gabriella .
MECHANISMS OF AGEING AND DEVELOPMENT, 2022, 206
[38]  
Matsuda Satoru, 2018, Diseases, V6, DOI [10.3390/diseases6020028, 10.3390/diseases6020028]
[39]   Tau and GSK-3β are Critical Contributors to α-Synuclein-Mediated Post-Stroke Brain Damage [J].
Mehta, Suresh L. ;
Kim, TaeHee ;
Chelluboina, Bharath ;
Vemuganti, Raghu .
NEUROMOLECULAR MEDICINE, 2023, 25 (01) :94-101
[40]  
Moghaddam SN, 2015, Research in Molecular Medicine, V3, P24, DOI 10.7508/rmm.2015.01.005